Dale Muzzey
Chief Scientific OfficerDr. Dale Muzzey, Ph.D., is Chief Scientific Officer of Myriad Genetics, Inc. from April 14, 2022. He was Senior VP of Research and Development & Interim Chief Scientific Officer of Myriad Genetics, Inc. from January 2022 to April 14, 2022 and Vice President, Bioinformatics, from October 2019 to December 2021 and Senior Director, Clinical Development from August 2018 to September 2019. From April 2014 to July 2018, Dr. Muzzey also served in a number of positions of increasing responsibility at Myriad Women's Health, including Director, Scientific Affairs, Staff Scientist, Computational Biology, Senior Scientist and Computational Scientist I. Dr. Muzzey received a Bachelor of Arts degree in Biochemical Sciences and a Ph.D. in Biophysics from Harvard University.
Positions
- Company NameMyriad Genetics, Inc.Stock CodeMYGNPositionChief Scientific OfficerColleagues
- SSSamraat S. RahaPresident, CEO & Director
- SLS. Louise PhanstielIndependent Chair of the Board
- BRBenjamin R. WheelerCFO & Principal Accounting Officer
- MSMark S. VerrattiChief Operating Officer
- PJPaul J. DiazConsultant
- HDHeinrich DreismannIndependent Director
- CFColleen Foley ReitanIndependent Director
- MSMark S. DavisIndependent Director
